N of 2 Responders with LMNA-NTRK1

J Natl Cancer Inst. 2015 Nov 12;108(1):djv376. doi: 10.1093/jnci/djv376. Print 2016 Jan.

Authors

Chih-Jian Lih¹, Alice P Chen²

Affiliations

¹ Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
² Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland chenali@mail.nih.gov.

PMID: 26563357
DOI: 10.1093/jnci/djv376

No abstract available

Publication types

Editorial

MeSH terms

Colorectal Neoplasms / genetics*
Colorectal Neoplasms / pathology
Fibrosarcoma / congenital
Fibrosarcoma / genetics*
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Fusion*
Gene Rearrangement*
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lamin Type A / genetics*
Proteins / genetics*
RNA, Neoplasm / analysis
Receptor, trkA / genetics*
Up-Regulation

Substances

LMNA protein, human
Lamin Type A
Proteins
RNA, Neoplasm
TFG protein, human
Receptor, trkA